Research and Development

Dated 16 April 2012, the European Commission has issued the Draft Template for the Written Confirmation for Active Substances Imported …

AstraZeneca is to buy Ardea Biosciences for $1 billion to help bolster its pipeline. Under the terms of the agreement, …

The European Medicines Agency has invited marketing-authorisation holders and other stakeholders to review and provide comments on the draft list …

A survey of pharma’s research partnerships and funding of UK academics has raised concerns about the future of British science.The …

The moment has arrived for the pharma industry to embrace online planning tools.The convergence of reliable and secure cloud-based computing, …

Merck is to pay $120 million to US biopharma company Endocyte as part of a deal to develop and commercialise …

John Lechleiter, chairman, president and chief executive of Lilly has been elected chairman of the Pharmaceutical Research and Manufacturers of …

Merck has entered a deal with a US venture capital firm specialising in life sciences to help build the manufacturer’s …

Pharma consultancy firm MSI has announced the appointment of a new partner.  Steve Mather takes up this senior position with …

Takeda is set to purchase URL Pharmaceuticals for $800 million, helping offset the loss of its blockbuster ulcer drug Prevacid.  …

The challenges that China and the wider Asia region face in healthcare represent big opportunities for multinational pharma companies. Cases of …

The European Medicines Agency says it wants to open up access to full clinical trial data, but warns that some …

immatics biotechnologies, a biopharma company developing therapeutic cancer vaccines, has appointment Dr Rainer Kramer as its new chief business officer. …

Pharma firms need to create closer and more flexible relationships with their contract research organisations for better outcomes. This is …

Johnson & Johnson has announced that Sheri McCoy, vice chairman of the executive committee, will leave the company on April …